On 24th November, The 2023 Shanghai Makers Competition was successfully held in Jianan District. Viva Biotech was honored with "the Best Partner of 2023 Shanghai Makers Carnival" award. The Viva BioInnovator (VBI), as the core department of Viva Biotech's investment and incubation business, is committed to being a collaborative platform for Innovative Biotech companies from around the world. By leveraging Viva Biotech’s rich experience and technical advantages in novel drug R&D, Viva BioInnovator is dedicated to providing a series of professional post-investment management solutions based on the various needs of new drug R&D and company growth stages to continuously optimize the biopharmaceutical innovation ecosystem. As of June 30, 2023, Viva BioInnovator has invested in and incubated 92 biotech start-ups in total, covering the fields of oncology, immune diseases, cardiovascular diseases, ophthalmic diseases, metabolic diseases, central nervous system diseases, infectious diseases, and other indications. During the competition, we shared our innovation experience and explore cooperation opportunities. Through exchanges with industrial partners, managing partners, and investment partners, we jointly ignited the innovation engine, helping to launch innovative projects and set them on a course for success.
This competition, themed "Meet Makers Today, Embrace Partnerships Tomorrow," highlights its unique features by gathering global science and innovation projects, connecting with the innovative needs of large enterprises, deeply building a maker community, and creating a multidimensional innovation ecosystem. It aims to synergize management, industry, and capital partners, encouraging makers to demonstrate innovative thinking, leverage their technological strengths, and enhance their business capabilities. This initiative showcases Shanghai's favorable business environment and vibrant atmosphere for innovation and entrepreneurship. This initiative aims to attract international teams and projects and transform Shanghai into the preferred global destination for science and technology incubation. Dr. Han Dai, Chief Innovation Officer of Viva Biotech and Head of Viva BioInnovator, attended the awarding ceremony in person.
Dr. Han Dai, Chief Innovation Officer of Viva Biotech and Head of Viva BioInnovator
The open innovation strategy of large enterprises has evolved from early directional exploration to precise, actionable exploration driven by specific scenarios. In general, large companies have access to a wealth of scenario resources and actively engage in cross-sectoral collaborative innovation. The innovation needs they identify are often crucial for the layout and expansion of the industrial ecosystem. The Maker Competition aims to synergize large enterprises with maker teams and businesses, unlocking supply and ecological chains, and adopting integrated innovation as a means to coordinate the industrial innovation ecosystem.
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
- About Us
-
CRO Services
BackCRO ServicesDiscovery Biology Services
- CDMO Services
- EFS Business
- News
- Careers
- Investor Relations
- Contact Us